Results 291 to 300 of about 5,289,946 (346)

IL4I1⁺ Macrophages and TDO2⁺ Myofibroblasts Drive AhR‐Mediated Immunosuppression and Ferroptosis Resistance in Solid Predominant Lung Adenocarcinoma

open access: yesAdvanced Science, EarlyView.
Solid predominant lung adenocarcinoma exhibits an immune‐excluded, ferroptosis‐resistant niche enriched with IL4I1⁺ TAMs and TDO2⁺ myCAFs. Spatial and multi‐omics analyses reveal AhR‐driven crosstalk that promotes T cell exhaustion and therapy resistance. Blocking AhR with CH‐223191 restores ferroptosis sensitivity, and its combination with ferroptosis
Zhaoxuan Wang   +16 more
wiley   +1 more source

SREBP2 confers ferroptosis resistance by targeting GPX4 in colorectal cancer. [PDF]

open access: yesApoptosis
Zhong H   +12 more
europepmc   +1 more source

The KDM6B/SLC10A2 Axis Suppresses MDSCs Recruitment via ERK/AP‐1 Signaling in Colorectal Cancer

open access: yesAdvanced Science, EarlyView.
In wild‐type intestinal epithelial cells, KDM6B demethylates SLC10A2 to promote its expression, after which SLC10A2 suppresses ERK phosphorylation, inhibiting AP‐1 (Fos/Jun) transcription and chemokine production. In KDM6B‐deficient intestinal epithelial cells, SLC10A2 methylation increases, and its expression decreases.
Zhibo Hu   +16 more
wiley   +1 more source

Five-Year Experience of Nationwide Implementation of Colorectal Cancer Screening in Sweden. [PDF]

open access: yesUnited European Gastroenterol J
Hreinsson JP   +4 more
europepmc   +1 more source

Expression and Clinical Significance of CD47 in Colorectal Cancer: A Review. [PDF]

open access: yesCancers (Basel)
Li Q   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy